期刊文献+

曲美他嗪对高血压病患者炎性因子及动脉弹性功能的影响 被引量:1

Effects of trimetazidine oninflammatory cytokines and arterial elasticity of hypertensive patients
暂未订购
导出
摘要 目的探讨曲美他嗪对高血压病患者炎性因子及动脉弹性功能的影响。方法 147例高血压病患者随机分为曲美他嗪治疗组(n=73),对照组(n=74)。均测量血压、检测血脂、高敏C反应蛋白(hs-CRP)、白介素6(IL-6)等血液指标。应用脉搏波速度自动测量系统进行颈动脉-股动脉脉搏波速度(CFPWV)检测,治疗6个月后再次测量上述指标。结果两组血压达标率无差异(67.6%vs 65.7%,P>0.05),其中CFPWV,hs-CRP、IC-6较治疗前明显降低(P<0.05)。与对照组相比,治疗组CFPWV,hs-CRP、IC-6,降低更显著。结论曲美他嗪通过抗炎作用可以改善高血压病患者的动脉弹性。 Objective To discuss the effects of trimetazidine on inflammatorycytokines and arterial elasticity of hypertensive patients. Methods 147 patientssuffered fromhypertension were randomlydivided into trimetazidine group( n = 73) and control group( n = 74). Blood pressure,blood lipids,high sensitive C reactive protein( hs-CRP) and interleukin-6( IL-6) of all the patients were tested. And automatic pulse wave velocity system was used to test the carotid-femoral pulse wave velocity( CFPWV). All the above indexes were tested again after treatment for 6 months. Results Thedifference of blood pressure between the two groups was no statistically significant( 67. 6% vs 65. 7%,P 0. 05). CFPWV,hs-CRP and IL-6 of both groupreduced markedly after treatment( P 0. 05). Compared to control group,CFPWV,hs-CRP,and IL-6 of the treatmentgroupreduced more than the control group( P 0. 05). Conclusions Trimetazidine could improve thearterial elasticity of hypertensive patientsthroughreducing inflammatory cytokines.
机构地区 泰安市中心医院
出处 《齐齐哈尔医学院学报》 2014年第3期322-324,共3页 Journal of Qiqihar Medical University
关键词 曲美他嗪 炎性因子 脉搏波传导速度 高血压病 Trimetazidine Inflammatory cytokines Pulse Wave Velocity Hypertension
  • 相关文献

参考文献2

二级参考文献23

  • 1Cohn JN. Vascular wall function as a risk marker for cardiovascular disease[J] .J Hypertens, 1999 Dec, 17 Suppl 5:S41-4.
  • 2Cohn JN, Finkelstein SM, MeVeigh GE, et al. Noninvasive pulse wave analysis for the early detection of the vascular disease [ J ]. Hypertension, 1993,26(3) :503.
  • 3Isnard RN, Pannier BM, Lanrent S, et al. Pulsatile diameter and elastic modulus of the aortic arch in essential hypertension: a noninvasire study[J] .J Am Coll Cardiol, 1989 Feb, 13(2):399- 405.
  • 4Asmar R, Benetos A, London G, et al. Aortic distensibility in normotensive, untreated and treated hypertensive patients[J] .Blood Press, 1995 Jan,4(1 ) :48 - 54.
  • 5McVeigh GE, Bratteli CW, Morgan DJ, et AL. Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis: aging and arterial compliance[J] .Hypertension ,1999 Jun,33(6) : 1392 - 8.
  • 6McVeigh G, Brennan G, Hayes R, et al. Vascular abnormalities in non- insulin- dependent diabetes mellitus identified by arterial waveform analysis[J] .Am J Med, 1993 Oct,95(4) :424 - 30.
  • 7Lane KV, Prisant LM. Noninvasive vascular compliance: shortterm aasessment of test repeatability[J] .Am J Hypertens, 2000,13:191A- 192A.
  • 8Verdecchia P, Reboldi G, Gattobigio R, et al. Atrial fibrillation inhypertension : predictors and outcome [ J] . Hypertension, 2003 ,41(2):218-223.
  • 9Devereux RB,Alonso DR, Lutas EM, et al. Eehocardiographic as-sessment of left ventricular hypertrophy : comparision to necropsyfindings[J]. Am J Cardiol, 1986,57(3) :450-458.
  • 10Mancia G,De Backer G,Dominiczak A, et al. 2007 Guidelines forthe management of arterial hypertension[ J]. European Heart Jour-nal, 2007,28(12):1462-1536.

共引文献31

同被引文献8

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部